![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | C07D 489/00 | (2006.01) |
C07D 489/08 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 31/485 | (2006.01) |
(11) | Number of the document | 2305683 |
(13) | Kind of document | T |
(96) | European patent application number | 10011792.8 |
Date of filing the European patent application | 2005-03-30 | |
(97) | Date of publication of the European application | 2011-04-06 |
(45) | Date of publication and mention of the grant of the patent | 2015-01-28 |
(46) | Date of publication of the claims translation | 2015-05-25 |
(30) | Number | Date | Country code |
557492 P | 2004-03-30 | US | |
601534 P | 2004-08-13 | US | |
620072 P | 2004-10-18 | US | |
648625 P | 2005-01-31 | US | |
651778 P | 2005-02-10 | US |
(72) |
Chapman, Robert, US
Rider, Lonn S., US
Hong, Qi, US
Kyle, Donald, US
Kupper, Robert, US
|
(73) |
EURO-CELTIQUE S.A.,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Farmacinė vaisto forma, apimanti oksikodoną, turintį mažiau nei 25 ppm 14-hidroksikodeinono |
Pharmaceutical dosage form comprising oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
Payment date | Validity (years) | Amount | |
2024-02-20 | 347.00 EUR |